General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Has T2 Biosystems (TTOO) Outpaced Other Medical Stocks This Year? | news.google.com • |
TTOO- StockTitan | news.google.com • |
T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor | news.google.com • |
T2 Biosystems (NASDAQ:TTOO) Share Price Crosses Above 50 Day Moving Average of $4.24 | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-05 | 2024-06 | 0 | N/A | N/A | N/A |
2024-05-06 | 2024-03 | 0 | -2.66 | N/A | N/A |
2023-11-14 | 2023-09 | 0 | -3.45 | N/A | N/A |
2023-08-07 | 2023-06 | 0 | -8 | N/A | N/A |
2023-05-23 | 2023-03 | 0 | -117 | N/A | N/A |
2023-03-13 | 2022-12 | 0 | N/A | N/A | N/A |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-10-17 | ADAMS LAURA LEE | Director | 37.00 | Conversion of Exercise of derivative security |
2023-09-14 | BERNARD THIERRY | Director | 7.32K | Conversion of Exercise of derivative security |
2024-02-13 | CR GROUP, L.P. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Conversion of Exercise of derivative security |
2023-09-14 | CUMMING JOHN W | Director | 5.26K | Conversion of Exercise of derivative security |
2023-09-14 | ELSBREE DAVID B | Director | 8.02K | Conversion of Exercise of derivative security |
2024-02-22 | GIBBS MICHAEL TERRENCE | General Counsel | 135.00 | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Gsa Capital Partners Llp | 40.35K | 284.88K | 0.01% |
Split | Date |
---|---|
1 : 100 | 2023-10-13 |
1 : 50 | 2022-10-13 |
TTOO to the moonif the moon is on the ground then that’s bout right
$TNXP the cheapest CoVid 19 vaccine will run tomorrow at $3 Penny Stocks To Buy Under $4: Tonix Pharmaceuticals Holding
We talked about Tonix Pharmaceuticals Holding (TNXP Stock Report) over the weekend. This came after TNXP had one of its most active days of the year. The only other day to outpace July 17th was earlier in the year in February. Thatâ€s when the penny stock saw a move to highs of $1.23 and traded more than 167 million shares. That was when the company announced a strategic collaboration with Southern Research to support the development of a vaccine, TNX-1800 to protect against COVID-19.
This month Tonix announced that it met its target enrollment of approximately 470 participants in a Phase 3 RELIEF trial of TNX-102 SL 5.6 mg. The treatment is in development as a non-opioid, centrally acting analgesic, taken daily at bedtime for the management of fibromyalgia. On the heels of that update, Tonix also announced a collaboration with Columbia University to study immune responses against COVID-19.
“This work may also guide the selection of appropriate individuals for COVID-19 vaccine trials, such as for Tonix's TNX-1800, based on a live replicating vector platform, which is designed to confer durable T cell immunity. It is also possible that new COVID-19 vaccines can be designed which will be tailored to individuals by precision medicine,†said Seth Lederman, M.D., President and Chief Executive Officer of Tonix. Keep in mind that the penny stock closed the week last week around $0.80 and has already started turning higher during premarket trading on Monday. Will this trend continue or is a pullback in store?
Ah. The morning dip.
I wouldn’t expect to see it under 2 bucks tomorrow, but now if you have the funds.
I don’t know if this applies but in advertising, the best day to send email blasts is Tuesday as statistics have shown that day is the day most people read them. Unless a pr is urgent and needs to get out, perhaps we will see one tomorrow.
Not sure upcoming earnings will show any real COVID success as they just launched the tests in late June and sought FDA approval in July. FDA approval right now to me seems like the big one.
Don’t worry about the sells today, it’s Friday a lot of people looking for weekend money.
Slap that ask! Whatever that means.
News. We need news!
The folks at $AYTU think Trump’s going to say something about Healight.
Friggen government always mentions Abbott for testing. What about our American made, faster test?
I wonder if PR will come out at 4:30pm like last time.
Wait for the 1.50 dip
Earnings is only 18 days away. There can only be good from here.
Yabadabadoooooooooooo
Yabadabadoooooooooooo
Yabadabadoooooooooooo
I’ll bet news hits at 4:30pm today like last time.
More buys than sales!